Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 12/20 | 0.36 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.32 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.32 |
| ▸ | ACACA | Q13085 | 1/20 | 0.31 |
| ▸ | RARA | P10276 | 1/20 | 0.31 |
| ▸ | RARB | P10826 | 1/20 | 0.31 |
| ▸ | RARG | P13631 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21319142 | 0.98 | PDK2 (0.34) | PDK2LIMK1ALOX5PDE7APDE7B | |
| SCHEMBL17425583 | 0.98 | LIMK1 (0.36) | PDK2LIMK1ALOX5ACACA | |
| SCHEMBL17425542 | 0.97 | PDK2 (0.35) | PDK2LIMK1ALOX5RARARARB | |
| SCHEMBL17425537 | 0.97 | LIMK1 (0.36) | PDK2LIMK1ALOX5ACACA | |
| SCHEMBL17425673 | 0.97 | LIMK1 (0.36) | PDK2LIMK1ALOX5ACACA | |
| SCHEMBL29986676 | 0.97 | LIMK1 (0.36) | PDK2LIMK1ALOX5ACACA | |
| SCHEMBL17640304 | 0.96 | PDK2 (0.36) | PDK2LIMK1ALOX5PDE7APDE7B | |
| SCHEMBL30103502 | 0.96 | LIMK1 (0.37) | PDK2LIMK1ALOX5ACACA | |
| SCHEMBL17425526 | 0.96 | LIMK1 (0.37) | PDK2LIMK1ALOX5ACACA | |
| SCHEMBL17640468 | 0.94 | PDK2 (0.36) | PDK2LIMK1ALOX5RARARARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170054087-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-02-23 | — | — | US | disclosed |
| US-20160093808-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-03-31 | — | — | US | disclosed |
| US-20160028021-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-01-28 | — | — | US | disclosed |
| EP-2966706-A2 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2016-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160028021-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OR10J3 | PDK2 1226/4885LIMK1 115/4885ALOX5 336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.